For millions across the globe, the world around them is obstructed by the formation of "blind spots", cloudiness of the eye, and severe tunnel vision that accompany retinitis pigmentosa or age-related macular degeneration. I-CEE provides a synthetic replacement for a patient’s defective photoreceptors by employing advances in camera and biomedical technology.
Because retinitis pigmentosa and age-related macular degeneration are progressive diseases, they may cause those affected to indirectly undergo a state of mental or emotional instability. The blind are more prone to feeling isolated and alone because the loss of eyesight may alter sleeping cycles; everyday tasks pose difficulties that are discouraging and daunting to face. I-CEE offers a lifestyle without the limitations established by poor vision, and a colorful reality that recipients can confidently look forward to.
For the first time in a long time, those blinded at birth, by AMD, or by retinitis pigmentosa will be able to exercise their independence. Bulky equipment or walking aids would become unnecessary. Only I-CEE is able to offer the physical, emotional, and mental freedom that comes with the ability to accomplish goals on one's own. A host of activities are within sight: recipients of I-CEE can expect a future in which time spent with family and friends is free from limitations of eye conditions.
Since I-CEE operates within the eye, patients living with photoreceptor-related diseases will be indistinguishable from those with natural eyesight, reducing the stigma and discrimination that may underlie visible aids. Their enhanced eyesight will enable them to gain more opportunities such as access to jobs that would have otherwise been difficult or impossible to attain. Additionally, I-CEE restores confidence and paves a way for successful social interactions.
I-CEE is designed to aid patients with retinitis pigmentosa, AMD, and selected types of congenital eye disorders (such as Stargardt's Disease) where the passageway to the brain is not obstructed by abnormalities. This specificity increases the practicality of I-CEE as it targets an explicit cause for blindness and is not a general blanket solution.
Since I-CEE is implanted inside the eye for an extended period of time, patients should be aware that the material used may cause infections or allergic reactions. Additionally, as a synthetic internal processing unit, I-CEE runs the risk of malfunctioning.